Impact of body size on first‐line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy
出版年份 2021 全文链接
标题
Impact of body size on first‐line
Helicobacter pylori
eradication success using vonoprazan and amoxicillin dual therapy
作者
关键词
-
出版物
HELICOBACTER
Volume 26, Issue 2, Pages -
出版商
Wiley
发表日期
2021-02-15
DOI
10.1111/hel.12788
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan
- (2020) Sho Suzuki et al. GUT
- Influence of clarithromycin on the bactericidal effect of amoxicillin in patients infected with clarithromycin-resistant strains of H. pylori
- (2020) Takahisa Furuta et al. GUT
- Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
- (2020) Yiran Wang et al. Frontiers in Pharmacology
- Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in Japan
- (2020) Takuji Gotoda et al. JOURNAL OF GASTROENTEROLOGY
- Vonoprazan‐containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance
- (2020) David Y Graham et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Increase in antibiotic resistant Helicobacter pylori in a University Hospital in Japan
- (2019) Chihiro Kageyama et al. Infection and Drug Resistance
- Development of Helicobacter pylori treatment: How do we manage antimicrobial resistance?
- (2019) Sho Suzuki et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Dual Therapy with Vonoprazan and Amoxicillin Is as Effective as Triple Therapy with Vonoprazan, Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori
- (2019) Takahisa Furuta et al. DIGESTION
- Prevalence of antibiotic resistance in Helicobacter pylori : a systematic review and meta-analysis in World Health Organization regions
- (2018) Alessia Savoldi et al. GASTROENTEROLOGY
- Pre-treatment with proton pump inhibitors decreases the success of primary Helicobacter pylori eradication using a vonoprazan-based regimen
- (2018) Satoshi Shinozaki et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Review: A Japanese population-based meta-analysis of vonoprazan versus PPI for Helicobacter pylori eradication therapy: Is superiority an illusion?
- (2017) Shou Quan Dong et al. HELICOBACTER
- Letter to the Editor
- (2017) Richard S Taylor Paediatrics & Child Health
- Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy forHelicobacter pylorieradication: a phase III, randomised, double-blind study
- (2016) Kazunari Murakami et al. GUT
- Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review
- (2016) Abdulaziz S. Alobaid et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- CYP2C19 polymorphism influencesHelicobacter pylorieradication
- (2016) Chao-Hung Kuo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Effect of dosing schemes of amoxicillin on eradication rates ofHelicobacter pyloriwith amoxicillin-based triple therapy
- (2013) Takahisa Furuta et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic Analysis of Piperacillin Administered with Tazobactam in Critically Ill, Morbidly Obese Surgical Patients
- (2013) Ashley W. Sturm et al. PHARMACOTHERAPY
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
- Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption
- (2012) Francis Megraud et al. GUT
- Adjustment of dosing of antimicrobial agents for bodyweight in adults
- (2009) Matthew E Falagas et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started